Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucolytic Solution Before Upper Endoscopy
NCT04641455Unknown
- Sponsor
- Nemocnice AGEL Ostrava-Vítkovice
- Start
- Dec 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acetylcysteine and simethicone in gastric cancer (GC) (4 arms), sponsored by Nemocnice AGEL Ostrava-Vítkovice. Primary endpoint: Visibility score evaluated by blinded performing endoscopist. Status: unknown.
02
Drugs
acetylcysteinesimethicone
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04641455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04641455.